LENZ — Lenz Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapNeutral

Annual balance sheet for Lenz Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	377	268	184	209	292
Net Total Accounts Receivable
Net Total Receivables	—	—	—	—	0.329
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	382	275	188	212	301
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	18.1	28.2	0.321	1.99	1.92
Long Term Investments
Other Long Term Assets
Total Assets	402	322	188	215	306
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	12.1	13	4.8	10.4	21.2
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	17.9	25.6	4.87	11.2	21.5
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	384	296	184	204	284
Total Liabilities & Shareholders' Equity	402	322	188	215	306
Total Common Shares Outstanding